Transradial middle meningeal artery embolization for chronic subdural hematoma using Onyx: case series. (29th June 2020)

• Record Type: Journal Article
• Authors: Rajah, Gary B; Waqas, Muhammad; Dossani, Rimal H; Vakharia, Kunal; Gong, Andrew D; Rho, Kyungduk; Housley, Steven B; Rai, Hamid H; Chin, Felix; Tso, Michael K; Snyder, Kenneth V; Levy, Elad I; Siddiqui, Adnan H; Davies, Jason M
• Is Part Of: Journal of neurointerventional surgery. Volume 12:Number 12(2020)
• Page Start: 1214
• Page End: 1218
• Publication Date: 2020-06-29
• Subjects: artery -- catheter -- subdural -- technique -- technology; Nervous system -- Surgery -- Periodicals; Cerebrovascular disease -- Surgery -- Periodicals; 617.48
• DOI: 10.1136/neurintsurg-2020-016185
• Languages: English
• ISSNs: 1759-8478

Abstract

Abstract : Background: Middle meningeal artery (MMA) embolization is an emerging therapy for the resolution of subacute or chronic subdural hematoma (CSDH). CSDH patients are often elderly and have several comorbidities. We evaluated our experience with transradial access (TRA) for MMA embolization using predominantly Onyx under conscious sedation. Methods: Data for consecutive patients who underwent transradial MMA embolization for CSDH during a 2-year period (2018–2019) were analyzed from a single-center, prospectively-maintained database. Patient demographics, comorbidities, ambulatory times, subdural hematoma resorption status, and guide catheter type were recorded. Conversion to femoral access and complication rates were also recorded. Univariate and multivariate analyses were performed. Results: Forty-six patients (mean age, 71.7±14.4 years) were included in this study. Mean CSDH size was 14±5.5 mm. Most (91.3%) TRA embolizations were performed with 6-French 0.071-inch Benchmark guide catheters (Penumbra). MMA embolization was successful in 44 patients (95.7%) (including two cases of TRA conversion). Twenty-one (48%) patients had a severe Charlson Comorbidity Index (> 5). Symptomatic improvement was noted in 39 of 44 patients (88.6%). Mean length of stay was 4±3 days. Patients were ambulated immediately postprocedure. At mean follow-up (8±4 weeks), 86.4% of patients had complete or partial CSDH resolution. Persistent use of antiplatelet agents after the procedure was associated with failed or minimal CSDH resorption (5 of 6, 83.3% vs 9 of 38 23.7% with complete or near-complete resolution; P=0.009). Conclusion: Transradial Onyx MMA embolization under conscious sedation is safe and effective for CSDH treatment. TRA may be especially useful in elderly patients with numerous comorbidities.